167 related articles for article (PubMed ID: 16147728)
1. Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome.
Kiran TS; Bethel J; Bhal PS
J Obstet Gynaecol; 2005 Apr; 25(3):253-6. PubMed ID: 16147728
[TBL] [Abstract][Full Text] [Related]
2. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
3. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
[TBL] [Abstract][Full Text] [Related]
6. The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome.
Dehghani-Firouzabadi R; Tayebi N; Ghasemi N; Tahmasbi Z
Acta Med Iran; 2010; 48(4):234-8. PubMed ID: 21279936
[TBL] [Abstract][Full Text] [Related]
7. [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].
Cox M U; Kingdom J; Whittle M; McNay M; Fleming J; Bowman A; Crossley J; Aitken D
Rev Chil Obstet Ginecol; 1995; 60(3):174-80. PubMed ID: 8728745
[TBL] [Abstract][Full Text] [Related]
8. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
9. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.
Weiss BD
J Fam Pract; 1988 Mar; 26(3):273-80. PubMed ID: 2450166
[TBL] [Abstract][Full Text] [Related]
10. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
11. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
12. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of combined serum biomarkers for adverse pregnancy outcomes.
Cohen JL; Smilen KE; Bianco AT; Moshier EL; Ferrara LA; Stone JL
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():89-94. PubMed ID: 25129153
[TBL] [Abstract][Full Text] [Related]
14. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
[TBL] [Abstract][Full Text] [Related]
15. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
[TBL] [Abstract][Full Text] [Related]
16. Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery.
Weiner CP; Grant SS; Williamson RA
Am J Perinatol; 1991 Jul; 8(4):263-8. PubMed ID: 1720619
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of maternal serum alpha fetoprotein for predicting pregnancy outcome in high risk pregnancies: an epidemiological perspective.
Pandey J; Talib VH; Loganey D; Yadav S
Indian J Pathol Microbiol; 1993 Apr; 36(2):104-9. PubMed ID: 7506236
[TBL] [Abstract][Full Text] [Related]
18. Very low second-trimester maternal serum alpha-fetoprotein: Association with high birth weight.
Baschat AA; Harman CR; Farid G; Chodirker BN; Evans JA
Obstet Gynecol; 2002 Apr; 99(4):531-6. PubMed ID: 12039105
[TBL] [Abstract][Full Text] [Related]
19. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
20. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
Bartha JL; Omar KM; Soothill PW
Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
